Golimumab, sold under the brand name Simponi, is a human monoclonal antibody which is used as an immunosuppressive medication. Golimumab targets tumor...
14 KB (1,061 words) - 20:28, 8 May 2024
Calcipotriol plus betamethasone dipropionate ointment. Efalizumab Infliximab Golimumab Low dose methotrexate Intralesional corticosteroid injection Available...
14 KB (1,415 words) - 13:43, 9 October 2024
and dispensing and should be avoided. Certolizumab pegol, etanercept, golimumab and infliximab are alternatives, including quality-assured biosimilars...
67 KB (4,835 words) - 05:59, 17 August 2024
Infliximab as well as other TNF inhibitors like adalimumab, certolizumab, and golimumab are currently the most common biologics used in the treatment of both...
28 KB (3,327 words) - 19:25, 25 July 2024
monoclonal antibody such as infliximab, adalimumab, certolizumab pegol, and golimumab, or with a circulating receptor fusion protein such as etanercept. Thalidomide...
33 KB (3,686 words) - 07:30, 20 May 2024
combining Interleukin-2 and Diphtheria toxin Interleukin-2 receptor binder golimumab Simponi rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis...
30 KB (2,882 words) - 11:11, 23 July 2024
effectiveness when used alone and better results are obtained when used together. Golimumab is effective when used with methotraxate. TNF inhibitors may have equivalent...
148 KB (16,082 words) - 23:08, 18 October 2024
drugs, such as etanercept, infliximab, adalimumab, certolizumab, and golimumab, target the inflammatory cytokine tumor necrosis factor-alpha (TNF-alpha)...
56 KB (5,992 words) - 03:13, 19 October 2024
psoriatic arthritis are TNF-α inhibitors, including infliximab, etanercept, golimumab, certolizumab pegol and adalimumab, as well as the IL-12/IL-23 inhibitor...
32 KB (3,438 words) - 14:55, 9 July 2024
(TNFα) Ungrouped Antibodies: Adalimumab Afelimomab Certolizumab pegol Golimumab Infliximab Nerelimomab Ozoralizumab Remtolumab Placulumab Decoy receptors:...
49 KB (6,232 words) - 07:00, 22 October 2024
used to treat HIV/AIDS that had $857 million in 2020 revenue; Simponi (golimumab), a human monoclonal antibody used as an immunosuppressive drug that had...
98 KB (9,657 words) - 08:07, 15 October 2024
cytokines. Four monoclonal antibodies (MAbs) (infliximab, adalimumab, golimumab, and certolizumab pegol) and one recombinant TNF-α decoy receptor, etanercept...
116 KB (13,058 words) - 21:40, 16 October 2024
anti-tumor necrosis factor treatment (such as infliximab, etanercept, golimumab, and adalimumab). In a clinical trial cyclosporine added to prednisone...
118 KB (12,855 words) - 01:05, 14 October 2024
lacks this capability. Other monoclonal antibodies targeting TNF-α are golimumab, adalimumab, and certolizumab pegol. Etanercept also binds and inhibits...
46 KB (4,047 words) - 21:12, 30 June 2024
decoy TNF receptor bDMARD filgotinib Janus kinase (JAK) inhibitor tsDMARD golimumab TNF inhibitor bDMARD gold salts (sodium aurothiomalate, auranofin) (seldom...
10 KB (869 words) - 17:44, 20 August 2024
Products under development include biosimilars of omalizumab, denosumab, golimumab, aflibercept, vedolizumab, and pembrolizumab. In November 2022, Alvogen...
11 KB (914 words) - 20:13, 22 June 2024
ulcerative colitis. The TNF inhibitors, including infliximab, adalimumab and golimumab, are used to inhibit this step during the treatment of ulcerative colitis...
142 KB (16,190 words) - 08:02, 25 October 2024
noted with certolizumab pegol, etanercept, infliximab, adalimumab, and golimumab. The lives of people with ankylosing spondylitis are profoundly affected...
59 KB (6,013 words) - 03:56, 22 October 2024
Complement component 5 Eculizumab TNF Adalimumab Afelimomab Certolizumab pegol Golimumab Infliximab Nerelimomab Interleukin Anakinra Basiliximab Bimekizumab Briakinumab...
7 KB (299 words) - 13:45, 27 April 2024
L04AB03 Afelimomab L04AB04 Adalimumab L04AB05 Certolizumab pegol L04AB06 Golimumab L04AB07 Opinercept L04AC01 Daclizumab L04AC02 Basiliximab L04AC03 Anakinra...
3 KB (367 words) - 15:37, 25 January 2024
tesirine Carlumab Cemiplimab Dupilumab Eldelumab Emapalumab Fresolimumab Golimumab Ianalumab† Lanadelumab Lenzilumab Lerdelimumab Lirentelimab Lirilumab...
38 KB (4,316 words) - 10:24, 26 August 2024
humanized, antibody-drug conjugate CD33 Acute myeloid leukemia 761060 Link golimumab Simponi Centocor 4/24/2009 subcutaneous fully human TNF Rheumatoid arthritis...
59 KB (4,170 words) - 07:03, 20 October 2024
Glofitamab Columvi BsAb humanized CD20, CD3 Y diffuse large B-cell lymphoma Golimumab Simponi mab human TNF-α Y rheumatoid arthritis, psoriatic arthritis, ankylosing...
137 KB (4,083 words) - 21:25, 19 October 2024
the same structure are differently prefixed, such as the adalimumab and golimumab, both of which are TNF inhibitors but differ in their chemical structure...
38 KB (3,088 words) - 05:02, 8 August 2024
(TNFα) Ungrouped Antibodies: Adalimumab Afelimomab Certolizumab pegol Golimumab Infliximab Nerelimomab Ozoralizumab Remtolumab Placulumab Decoy receptors:...
8 KB (316 words) - 13:53, 10 September 2024
(TNFα) Ungrouped Antibodies: Adalimumab Afelimomab Certolizumab pegol Golimumab Infliximab Nerelimomab Ozoralizumab Remtolumab Placulumab Decoy receptors:...
8 KB (501 words) - 13:55, 10 September 2024
include biologics such as monoclonal antibodies against TNF (infliximab, golimumab, certolizumab) or the IL-6 receptor (tocilizumab) as well as Janus kinase...
39 KB (3,414 words) - 20:32, 25 September 2024
(TNFα) Ungrouped Antibodies: Adalimumab Afelimomab Certolizumab pegol Golimumab Infliximab Nerelimomab Ozoralizumab Remtolumab Placulumab Decoy receptors:...
12 KB (1,387 words) - 13:47, 4 September 2024
(TNFα) Ungrouped Antibodies: Adalimumab Afelimomab Certolizumab pegol Golimumab Infliximab Nerelimomab Ozoralizumab Remtolumab Placulumab Decoy receptors:...
24 KB (2,809 words) - 11:12, 20 August 2024
(INN) Glyset glysobuzole (INN) Go-Evac gold (198 Au), colloidal (INN) golimumab (INN) golnerminogene pradenovec (USAN, INN) golotimod (USAN, INN) Golytely...
14 KB (637 words) - 20:46, 27 August 2024